Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity.
Genome Biol. 2014;15(11):540. doi: 10.1186/PREACCEPT-1724277741482641.
Genome Biol. 2014.
PMID: 25416632
Free PMC article.
Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions.
Dowall SD, Graham VA, Corbin-Lickfett K, Empig C, Schlunegger K, Bruce CB, Easterbrook L, Hewson R.
Dowall SD, et al. Among authors: schlunegger k.
J Immunol Res. 2015;2015:347903. doi: 10.1155/2015/347903. Epub 2015 Mar 1.
J Immunol Res. 2015.
PMID: 25815346
Free PMC article.
Item in Clipboard
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody.
Dowall S, Taylor I, Yeates P, Smith L, Rule A, Easterbrook L, Bruce C, Cook N, Corbin-Lickfett K, Empig C, Schlunegger K, Graham V, Dennis M, Hewson R.
Dowall S, et al. Among authors: schlunegger k.
Antiviral Res. 2013 Feb;97(2):108-11. doi: 10.1016/j.antiviral.2012.11.003. Epub 2012 Nov 16.
Antiviral Res. 2013.
PMID: 23165089
Item in Clipboard
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB.
Kasikara C, et al. Among authors: schlunegger k.
Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9.
Mol Cancer Res. 2017.
PMID: 28184013
Free PMC article.
Item in Clipboard
r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.
Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA.
Sullivan LA, et al. Among authors: schlunegger k.
PLoS One. 2010 Aug 6;5(8):e12031. doi: 10.1371/journal.pone.0012031.
PLoS One. 2010.
PMID: 20700512
Free PMC article.
Item in Clipboard
Cite
Cite